Hoener MC

Neuroscience Research, pRED, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Basel, Switzerland.

6 papers · ORCID

ArticlePsychedelics

Receptor interaction profiles of 4-alkoxy-2,6-dimethoxyphenethylamines (Ψ derivatives) and related amphetamines.

Kolaczynska KE, Trachsel D, Hoener MC +2

Europe PMC2025
ArticlePsychedelics

The 4-alkyl chain length of 2,5-dimethoxyamphetamines differentially affects in vitro serotonin receptor actions versus in vivo psychedelic-like effects.

Luethi D, Glatfelter GC, Pottie E +12

Europe PMC2026
ArticlePsilocybin

<i>In vitro</i> and <i>in vivo</i> metabolism of psilocybin's active metabolite psilocin.

Thomann J, Kolaczynska KE, Stoeckmann OV +7

Europe PMC2024
ArticlePsychedelics

Use of the head-twitch response to investigate the structure-activity relationships of 4-thio-substituted 2,5-dimethoxyphenylalkylamines.

Halberstadt AL, Luethi D, Hoener MC +3

Europe PMC2023
ArticleMescaline

Receptor Interaction Profiles of 4-Alkoxy-3,5-Dimethoxy-Phenethylamines (Mescaline Derivatives) and Related Amphetamines.

Kolaczynska KE, Luethi D, Trachsel D +2

Europe PMC2021
ArticlePsilocybin

Receptor interaction profiles of novel psychoactive tryptamines compared with classic hallucinogens.

Rickli A, Moning OD, Hoener MC +1

Europe PMC2016